Varex Imaging (NASDAQ:VREX) Stock Crosses Below 50-Day Moving Average – What’s Next?

Shares of Varex Imaging (NASDAQ:VREX) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $11.09 and traded as low as $9.41. Varex Imaging shares last traded at $9.70, with a volume of 621,258 shares.

Analyst Ratings Changes

A number of brokerages have commented on VREX. Jefferies Financial Group reiterated a “hold” rating and issued a $14.50 price objective on shares of Varex Imaging in a report on Monday, February 2nd. Zacks Research upgraded shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a report on Monday, April 13th. Wall Street Zen lowered shares of Varex Imaging from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th. Finally, B. Riley Financial restated a “buy” rating on shares of Varex Imaging in a research note on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Varex Imaging currently has an average rating of “Moderate Buy” and a consensus target price of $16.17.

Varex Imaging Trading Up 0.4%

The company has a current ratio of 3.20, a quick ratio of 1.43 and a debt-to-equity ratio of 0.67. The business’s 50-day moving average is $11.09 and its two-hundred day moving average is $12.07. The firm has a market cap of $408.37 million, a P/E ratio of -4.85 and a beta of 0.96.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. The business had revenue of $216.00 million for the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. As a group, analysts expect that Varex Imaging will post 0.93 earnings per share for the current fiscal year.

Insider Buying and Selling at Varex Imaging

In related news, Director Jay K. Kunkel sold 4,510 shares of the business’s stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $11.14, for a total transaction of $50,241.40. Following the completion of the sale, the director owned 23,450 shares of the company’s stock, valued at $261,233. This represents a 16.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 4.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. State of Alaska Department of Revenue bought a new position in Varex Imaging in the 3rd quarter worth about $27,000. Rockefeller Capital Management L.P. bought a new position in Varex Imaging in the 4th quarter worth about $27,000. Quarry LP bought a new position in Varex Imaging in the 3rd quarter worth about $64,000. BNP Paribas Financial Markets grew its position in Varex Imaging by 18.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock worth $113,000 after purchasing an additional 2,036 shares during the last quarter. Finally, Aquatic Capital Management LLC bought a new position in Varex Imaging in the 3rd quarter worth about $117,000.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.